(Q37270478)

English

Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening

scientific article published on 30 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Yasuhide Kitagawa

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Atsushi Mizokami

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Mikio Namiki

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

30 June 2013

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Prostate international

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

65-68

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814114

6 September 2017

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814114

6 September 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814114

6 September 2017

Current activities and future directions of the cancer registration system in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814114

14 September 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814114

3 September 2018

Recent trends in prostate cancer mortality show a continuous decrease in several countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814114

20 October 2018

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814114

3 December 2018

Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion

1 reference

https://pubmed.ncbi.nlm.nih.gov/24223404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.12954/PI.12017

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37270478&oldid=2131681603"